Author:
Schober C.,Beyer J. M.,Fiorentzis M.,Viestenz A.
Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Campbell M, Collery R, McEvoy A et al (2006) Involvement of MAPKs in endostatinmediated regulation of blood-retinal barrier function. Curr Eye Res 31:1033–1045. https://doi.org/10.1080/02713680601013025
2. Tyagi P, Santiago C (2018) New features in MEK retinopathy. BMC Ophthalmol 18(Suppl 1):221. https://doi.org/10.1186/s12886-018-0861-8
3. Ludeke I, Terheyden P, Grisanti S, Luke M (2016) Development of serous retinopathy during therapy of a metastatic cutaneous melanoma. Ophthalmologe 113(10):861–863. https://doi.org/10.1007/s00347-016-0226-8
4. Draganova D, Kerger J, Caspers L, Willermain F (2015) Severe bilateral panuveitis during melanoma treatment by Dabrafenib and Trametinib. J Ophthalmic Inflamm Infect 5:17. https://doi.org/10.1186/s12348-015-0049-9
5. Abbasova J, Siedlecki J, Bayerl-Löhe K, Priglinger S, Berking C, Eibl-Lindner K (2016) CCs-artige Retinopathie in der Therapie des malignen Melanoms: Korrelation mit kumulativer Dosis oder Stadium der Erkrankung? https://www.dog.org/wp-content/uploads/2016/09/Abbasova-DOG-2016.pdf. Zugegriffen: 15.12.2019